A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation
Donor cell-derived hematologic neoplasms are rare but significant complications after HSCT. Early diagnosis and intervention are crucial to improving patient prognosis. Further studies are needed to better understand the pathogenesis of this condition and develop more effective therapeutic strategies.
Authors
- Tomasz Wróbel (ORCID: https://orcid.org/0000-0002-6612-3535)
- Aleksandra Mroczkowska-Bękarciak
Institutions
- Wroclaw Medical University (PL)
Publication Details
- Journal
- Oncotarget
- Published
- 2025-02-05
- DOI
- https://doi.org/10.18632/oncotarget.28686
- Citations
- 2
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 3.54